Patterson Companies

Patterson Cos., Inc. provides products, technologies, services, and business solutions to the dental and animal health markets. It operates through the following segments: Dental, Animal Health, and Corporate. The Dental segment provides consumable dental products, equipment and software, turnkey digital solutions, and value-added services to dentists, dental laboratories, institutions, and other healthcare professionals. The Animal Health segment distributes animal health products, services, and technologies to both the production-animal and companion-pet markets. The Corporate segment consists of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources, and facilities. The company was founded by John Patterson and Myron Fayette Patterson in 1877 and is headquartered in St. Paul, MN.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Patterson Companies Inc. reports strong Q4 performance and outlines growth strategies for fiscal 2024

Patterson Companies Inc. delivered strong financial results for Q4 2023, with a focus on sustained margin improvement and strategic growth opportunities. Despite challenges in free cash flow and market moderation, the company is well-positioned to leverage its strengths and capitalize on opportunities in the dental and animal health segments.

Patterson Companies Inc. reports strong Q2 earnings and focuses on private label growth

Patterson Companies Inc. delivered strong financial performance in Q2 2023, driven by growth in both the Dental and Animal Health segments. The company reaffirmed fiscal '24 earnings guidance and highlighted the potential of private label products. Despite tax and interest rate challenges, the company remains optimistic and focused on strategic initiatives to drive future growth.

Patterson Companies excels in Q3, eyes international growth opportunities

Patterson Companies reported a strong Q3 performance with internal sales growth and margin improvements. Challenges in the Dental segment were offset by growth in the Animal Health segment. The company highlighted strategic acquisitions, leadership appointments, and operational enhancements as key drivers of success. Opportunities lie in stable patient traffic, international investments, and exploring M&A in dental specialties for future growth.

Patterson Companies reports strong Q4 performance and strategic growth focus

Patterson Companies had a robust Q4 performance, showcasing growth in sales and margins. Despite challenges in the companion animal market, the company is strategically positioned for growth through software investments and service enhancements. Opportunities lie in sustained sales growth, margin expansion, and strategic market positioning.

Patterson Companies reports strong Q1 results amidst strategic focus

Patterson Companies delivered strong Q1 '24 results with growth in sales and adjusted EPS. The company is strategically focusing on private label products and efficiency improvements. While facing challenges like deflationary impacts and inflationary pressures, Patterson sees opportunities in Dental equipment growth and continued investments for long-term profitability.

Patterson Companies reports strong Q2 performance amidst market challenges

Patterson Companies delivered a solid performance in Q2 2024, driven by growth in Dental and Animal Health segments.
Despite challenges like macroeconomic headwinds and pricing pressures, the company remains focused on efficiency and driving demand.
Opportunities exist for Patterson to capitalize on market trends, optimize operations, and explore new growth avenues.
Investors should monitor how Patterson navigates challenges and leverages strengths to achieve its revised fiscal guidance.

Patterson Companies reports solid Q3 performance amidst market challenges

Patterson Companies delivered a solid performance in Q3 2024, with a focus on revenue growth, margin expansion, and strategic investments in distribution and software offerings.
While facing challenges in certain segments, the company remains committed to operational efficiency, margin integrity, and long-term growth initiatives.
Opportunities lie in sustaining sales growth, expanding market presence, and capitalizing on improvements in equipment demand and margin enhancement.
Overall, Patterson's strategic focus on growth, efficiency, and innovation positions the company for long-term success in the market.

Patterson Companies Reports Stable Q4, Eyes Strategic Growth

Patterson Companies concluded fiscal 2024 with stable financial performance, facing some headwinds in the Dental segment but offset by gains in Animal Health and strategic tech investments. The company is poised for modest growth in 2025, backed by ongoing investments in high-margin areas and a strong focus on innovation and market expansion.

Patterson Companies addresses challenges in Q1 2025 earnings call

Patterson Companies faced challenges in Q1 2025, with declines in both the Dental and Animal Health segments.
Despite these challenges, management is taking actions to improve performance and profitability for the rest of fiscal 2025.
The company's focus on cost management and operational efficiency is a strength in navigating the current environment.
Opportunities exist in strengthening the companion animal business, improving internal sales, and enhancing cybersecurity measures.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Patterson Cos., Inc. engages in the provision of products, technologies, services, and business solutions to the dental and animal health markets. It operates through the following segments: Dental, Animal Health, and Corporate. The Dental segment provides consumable dental products, equipment and software, turnkey digital solutions, and value-added services to dentists, dental laboratories, institutions, and other healthcare professionals. The Animal Health segment distributes animal health products, services, and technologies to both the production-animal and companion-pet markets. The Corporate segment consists of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources, and facilities. The company was founded by John Patterson and Myron Fayette Patterson in 1877 and is headquartered in St. Paul, MN.

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (Nasdaq: PDCO) today reported consolidated net sales of $1.6 billion (see attached Sales Summary for further details) in its fiscal third quarter ended January 29, 2022, an increase of 2.9 percent compared to the same period last year. Internal sales, which are adjusted for the effects of currency translation, changes in product selling relationships and contributions from recent acquisitions, increased 4.3 percent over the prior year.

Patterson Companies Reports Fiscal 2022 Third-Quarter Operating Results

Patterson Companies' (PDCO) fiscal third-quarter results are likely to reflect improvement at Animal Health segment.

What's in Store for Patterson Companies' (PDCO) Q3 Earnings?

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies (Nasdaq: PDCO) today announced that it will hold its fiscal 2022 third-quarter conference call on Wednesday, March 2, 2022 at 7:30 a.m. CT (8:30 a.m. ET). The company's earnings release will be issued that morning before the market opens. To access the live webcast, go to the investor relations section of the company's website, www.PattersonCompanies.com. The third-quarter fiscal 2022 earnings conference call replay will be available beginni

Patterson Companies Fiscal 2022 Third-Quarter Conference Call Scheduled for Wednesday, March 2, 2022

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies Inc. (Nasdaq: PDCO), a value-added distributor focused on providing best-in-class products, services, technology and experiences to the dental and animal health markets, announced today that the Company will present virtually at the 2022 J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022 at 9:00 a.m. Eastern time. The conference brings together leaders from across the healthcare industry, emerging fast-growth companies and inno

Patterson Companies to Present at the 2022 J.P. Morgan Healthcare Conference

Patterson Companies (PDCO) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.

Patterson Companies (PDCO): The Perfect Mix of Value and Rising Earnings Estimates?

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (Nasdaq: PDCO) today announced that Philip McKoy has been elected to the Patterson Companies Board of Directors, effective December 13, 2021. Mr. McKoy currently serves as Chief Information Officer of Optum, the health technology and services business of UnitedHealth Group. Mr. McKoy will serve on the Board's Audit Committee. “As we continue to leverage technology to further enhance Patterson's value proposition, we are excited to welc

Patterson Companies Elects Philip McKoy to Board of Directors

Patterson Cos. (PDCO) is technically in oversold territory now, so the heavy selling pressure might have exhausted.

After Plunging 15.7% in 4 Weeks, Here's Why the Trend Might Reverse for Patterson Cos. (PDCO)

Patterson Cos. (PDCO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects.

Patterson Cos. (PDCO) Moves to Buy: Rationale Behind the Upgrade

Patterson Companies, Inc. (PDCO) CEO Mark Walchirk on Q2 2022 Results - Earnings Call Transcript

Patterson Companies' (PDCO) fiscal second-quarter 2022 results benefit from strength in the Animal Health segment.

Patterson Companies (PDCO) Beats on Q2 Earnings & Revenues

Patterson Companies Inc (NASDAQ: PDCO) reported Q2 FY22 sales of $1.65 billion, +6.2% Y/Y, beating the consensus of $1.58 billion. Dental segment sales reached $622.2 million.

Patterson Companies Q2 Earnings Beat Street View, Raises FY22 Adjusted EPS Outlook

Patterson Cos. (PDCO) delivered earnings and revenue surprises of 16% and 4.24%, respectively, for the quarter ended October 2021.

Patterson Cos. (PDCO) Q2 Earnings and Revenues Surpass Estimates

Patterson Cos. Inc. PDCO, -4.11% said Wednesday it had net income of $48.3 million, or 49 cents a share, in its fiscal second quarter to Oct. 30, down from $54.1 million, or 56 cents a share, in the year-earlier period.

Patterson Cos. beats Q2 earnings estimates and raises guidance

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (Nasdaq: PDCO) today reported consolidated net sales of $1.65 billion (see attached Sales Summary for further details) in its fiscal second quarter ended October 30, 2021, an increase of 6.2 percent compared to the same period last year. Internal sales, which are adjusted for the effects of currency translation, changes in product selling relationships and contributions from recent acquisitions, increased 8.3 percent over the prior yea

Patterson Companies Reports Fiscal 2022 Second-Quarter Operating Results

Patterson Companies' (PDCO) fiscal second-quarter results are likely to reflect improvement at Dental segment.

What's in Store for Patterson Companies' (PDCO) Q2 Earnings?

AstraZeneca

Bristol-Myers

CVS Health

Novartis

Needless to say, 2021 has been a banner year for equities, with the S&P 500 up a stunning 25%.

Top Strategist Says Health Care Could Rule in 2022: 5 Dividend Winners

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies (Nasdaq: PDCO) today announced that it will hold its fiscal 2022 second-quarter conference call on Wednesday, December 1, 2021 at 7:30 a.m. CT (8:30 a.m. ET). The company's earnings release will be issued that morning before the market opens. To access the live webcast, go to the investor relations section of the company's website, www.PattersonCompanies.com. The second-quarter fiscal 2022 earnings conference call replay will be available be

Patterson Companies Fiscal 2022 Second-Quarter Conference Call Scheduled for Wednesday, December 1, 2021

West Pharmaceutical Services

PDCO vs. WST: Which Stock Is the Better Value Option?

PDCO vs. WST: Which Stock Should Value Investors Buy Now?

Patterson Companies, Inc. (PDCO) CEO Mark Walchirk on Q1 2022 Results - Earnings Call Transcript

Patterson Companies Inc (NASDAQ: PDCO) reported Q1 FY22 sales of $1.61 billion, +29.6% Y/Y, beating the consensus of $1.44 billion. "Our fiscal first-quarter results reflect the continued momentum we are building across our Dental and Animal Health businesses and Patterson's position of strength in the market," said Mark Walchirk, President and CEO.

Investors Cheer Patterson Companies' FY22 Guidance Update

Patterson Companies' (PDCO) fiscal first-quarter 2022 results benefit from strong segmental performance.

Patterson Companies (PDCO) Q1 Earnings & Revenues Top Estimates

Patterson Cos. (PDCO) delivered earnings and revenue surprises of 13.16% and 9.96%, respectively, for the quarter ended July 2021.

Patterson Cos. (PDCO) Q1 Earnings and Revenues Beat Estimates

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (Nasdaq: PDCO) today reported consolidated net sales of $1.61 billion (see attached Sales Summary for further details) in its fiscal first quarter ended July 31, 2021, an increase of 29.6 percent compared to the same period last year. Sales in the first quarter 2022 reflect an extra week of sales results versus the prior year. Internal sales, which are adjusted for the effects of currency translation, changes in product selling relatio

Patterson Companies Reports Fiscal 2022 First-Quarter Operating Results

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies (Nasdaq: PDCO) today announced that it will hold its fiscal 2022 first-quarter conference call on Thursday, September 2, 2021 at 7:30 a.m. CT (8:30 a.m. ET). The company's earnings release will be issued that morning before the market opens. To access the live webcast, go to the investor relations section of the company's website, www.PattersonCompanies.com. The first-quarter fiscal 2022 earnings conference call replay will be available begi

Patterson Companies Fiscal 2022 First-Quarter Conference Call Scheduled for Thursday, September 2, 2021

Patterson Cos. (PDCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

News for Patterson Companies Stock (PDCO)